A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.
Q4 2025 Earnings Call February 27, 2026 8:00 AM ESTCompany ParticipantsTrip TaylorJohn Treace - Founder, Chairman ...